{
  "schema": "pestle.medicine.v1",
  "url": "https://pestle.health/uk/opicapone",
  "country": "GB",
  "medicine": "Opicapone",
  "activeIngredient": "opicapone",
  "source": {
    "type": "Patient information leaflet approved by the UK medicines regulator (MHRA)",
    "product": "Ongentys 50 mg Hard Capsules",
    "licenceNumber": "PLGB215660004",
    "url": "https://mhraproducts4853.blob.core.windows.net/docs/699687cc485710a4ec5be2f7ba87a9071381f933",
    "leafletDate": "2026-08-07"
  },
  "checkedAgainstSource": "2026-11-19",
  "automatedCheck": {
    "sideEffectsListed": 39,
    "wordingFoundInLeaflet": 39,
    "notFound": 0
  },
  "reviewedBy": null,
  "whatItIsFor": "Ongentys is used to treat Parkinson's disease and the movement problems that go with it. It is for adults who already take levodopa with a DOPA decarboxylase inhibitor, and it boosts the effect of levodopa.",
  "keyFacts": [
    "The recommended dose is 50 mg once daily, preferably at bedtime.",
    "Take it at least one hour before or after your levodopa medicine.",
    "Swallow the capsule whole with a glass of water.",
    "Do not stop taking it unless your doctor tells you to, as your symptoms may get worse.",
    "It may make you feel light-headed, dizzy or sleepy when taken with levodopa, so do not drive or use machinery if this happens."
  ],
  "doNotTake": [
    "if you are allergic to opicapone or any of the other ingredients",
    "if you have a tumour of the adrenal gland (phaeochromocytoma), or of the nervous system (paraganglioma), or any other tumour that increases the risk of severe high blood pressure",
    "if you have ever had neuroleptic malignant syndrome, a rare reaction to antipsychotic medicines",
    "if you have ever had the rare muscle disorder rhabdomyolysis that was not caused by injury",
    "if you are taking certain antidepressants called monoamine-oxidase (MAO) inhibitors (e.g. phenelzine, tranylcypromine or moclobemide); ask your doctor or pharmacist if you can take your antidepressant with Ongentys"
  ],
  "checkWithDoctorFirst": [
    "if you have severe liver problems and have had loss of appetite, weight loss, weakness or exhaustion within a short period of time",
    "if you or your family/carer notice urges or cravings to behave in unusual ways or you cannot resist the impulse to do things that could harm you or others (impulse control disorders), such as addictive gambling, an abnormally high sex drive or increased preoccupation with sexual thoughts or feelings",
    "children and adolescents under 18 years must not take this medicine"
  ],
  "seriousSideEffects": [
    "Any side effect at the start of treatment: contact your doctor straight away"
  ],
  "sideEffectsByFrequency": [
    {
      "frequency": "Very common",
      "meaning": "More than 1 in 10 people",
      "effects": [
        "involuntary and uncontrollable, or difficult or painful body movements"
      ]
    },
    {
      "frequency": "Common",
      "meaning": "Up to 1 in 10 people",
      "effects": [
        "constipation",
        "dry mouth",
        "feeling sick (nausea)",
        "vomiting (being sick)",
        "increased levels of the enzyme (creatine kinase) in your blood",
        "muscle spasm",
        "dizziness",
        "headache",
        "sleepiness",
        "difficulty falling or staying asleep",
        "strange dreams",
        "experiencing or seeing things which do not exist (hallucinations)",
        "a fall in blood pressure on standing up which causes dizziness, light-headedness or fainting"
      ]
    },
    {
      "frequency": "Uncommon",
      "meaning": "Up to 1 in 100 people",
      "effects": [
        "palpitations or irregular heartbeat",
        "blocked ear",
        "dry eye",
        "pain or swelling of the abdomen",
        "indigestion",
        "weight loss",
        "loss of appetite",
        "increased levels of triglycerides (fats) in your blood",
        "muscle twitching, stiffness or pain",
        "pain in arms or legs",
        "altered sense of taste",
        "excessive body movements",
        "fainting",
        "anxiety",
        "depression",
        "hearing things which do not exist",
        "feeling confused",
        "nightmares",
        "sleep disorder",
        "abnormal colour of urine",
        "need to wake and pass urine at night",
        "shortness of breath",
        "high or low blood pressure",
        "having falls",
        "feeling low in energy or tired"
      ]
    }
  ],
  "otherMedicinesTheLeafletMentions": [
    "medicines for depression or anxiety such as venlafaxine, maprotiline and desipramine",
    "safinamide, used for Parkinson's disease",
    "medicines to treat asthma such as rimiterole or isoprenaline",
    "medicines to treat allergic reactions such as adrenaline",
    "medicines to treat heart failure such as dobutamine, dopamine or dopexamine",
    "medicines for high cholesterol such as rosuvastatin, simvastatin, atorvastatin or pravastatin",
    "medicines that affect the immune system such as methotrexate",
    "medicines containing quinidine (used for abnormal heart rhythms or malaria)",
    "any other medicines you are taking, have recently taken or might take"
  ],
  "pregnancyAndBreastfeeding": "Ongentys is not recommended during pregnancy, and you should use effective contraception if you might become pregnant. It is not known if it passes into breast milk and the risk to the baby cannot be excluded, so you should stop breast-feeding during treatment.",
  "howToTake": [
    "The recommended dose is 50 mg once daily, preferably at bedtime.",
    "Take it at least one hour before or after your levodopa medicine.",
    "Swallow the capsule whole with a glass of water.",
    "If you forget a dose, carry on and take the next dose as scheduled; do not take a double dose.",
    "The dose of your other Parkinson's disease medicines may need adjusting when you start, so follow your doctor's instructions."
  ],
  "notice": "Reference information taken from the official leaflet. Not medical advice. Other makers of the same medicine may publish slightly different leaflets."
}